1. Home
  2. DLTR vs ILMN Comparison

DLTR vs ILMN Comparison

Compare DLTR & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dollar Tree Inc.

DLTR

Dollar Tree Inc.

N/A

Current Price

$129.44

Market Cap

24.2B

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$122.13

Market Cap

20.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLTR
ILMN
Founded
1986
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2B
20.4B
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
DLTR
ILMN
Price
$129.44
$122.13
Analyst Decision
Hold
Hold
Analyst Count
18
17
Target Price
$122.88
$124.24
AVG Volume (30 Days)
2.7M
2.2M
Earning Date
03-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
170.87
EPS
3.72
5.45
Revenue
$17,578,500,000.00
$4,343,000,000.00
Revenue This Year
$12.95
$6.56
Revenue Next Year
$6.27
$5.49
P/E Ratio
$34.33
$22.43
Revenue Growth
N/A
N/A
52 Week Low
$61.80
$68.70
52 Week High
$142.40
$155.53

Technical Indicators

Market Signals
Indicator
DLTR
ILMN
Relative Strength Index (RSI) 50.62 40.90
Support Level $113.11 $114.88
Resistance Level $132.48 $126.00
Average True Range (ATR) 4.29 4.00
MACD 0.34 0.39
Stochastic Oscillator 42.64 57.29

Price Performance

Historical Comparison
DLTR
ILMN

About DLTR Dollar Tree Inc.

Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2024, Dollar Tree generated over $17 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: